MultiStem

Athersys stroke treatment fails mid-stage study
Athersys stroke treatment fails mid-stage study
Yahoo/Reuters
Athersys
stroke
MultiStem
Flag link:
The Biggest Biotech Catastrophes of the Week
The Biggest Biotech Catastrophes of the Week
Motley Fool
biotech
vintafolide
Endocyte
OncoGenex
custirsen
Athersys
MultiStem
Flag link:
Athersys stem-cell therapy for bowel disease fails in study
Athersys stem-cell therapy for bowel disease fails in study
Yahoo/Reuters
Athersys
stem cells
inflammatory bowel disease
Pfizer
MultiStem
Flag link:
3 Biotechs Expecting Top Line Phase 2 Data Mid 2014
3 Biotechs Expecting Top Line Phase 2 Data Mid 2014
Seeking Alpha
Biota Pharmaceuticals
Laninamivir Octanoate
Flu
Inovio
VGX-3100
DNA vaccines
MultiStem
Athersys
Pfizer
ulcerative colitis
Flag link:
2 Cell Therapy Companies That Could Thrive With Cardiovascular Disease Treatments
2 Cell Therapy Companies That Could Thrive With Cardiovascular Disease Treatments
Seeking Alpha
stem cells
cardiovascular disease
Athersys
NeoStem
AMR-001
MultiStem
Flag link:
Athersys: Two Crucial Near-Term Events
Athersys: Two Crucial Near-Term Events
Seeking Alpha
Athersys
MultiStem
stem cells
Osiris
RTI Surgical
Flag link:
Athersys: Remarkable Treatment For Ischemic Stroke Feasibly On The Way
Athersys: Remarkable Treatment For Ischemic Stroke Feasibly On The Way
Seeking Alpha
Athersys
ischemic stroke
stroke
MultiStem
stem cells
Flag link:
Athersys: A Potential Stroke Therapy Monopoly On Hand
Athersys: A Potential Stroke Therapy Monopoly On Hand
Seeking Alpha
stroke
Athersys
Cytomedix
MultiStem
Flag link:
Athersys, Inc.: Clinical Trial For Inflammatory Bowel Disease
Athersys, Inc.: Clinical Trial For Inflammatory Bowel Disease
Seeking Alpha
Athersys
inflammatory bowel disease
clinical trials
MultiStem
stem cells
Flag link:
Athersys' MultiStem Platform Tempts Big Pharma And Investors
Athersys' MultiStem Platform Tempts Big Pharma And Investors
Seeking Alpha
Athersys
MultiStem
Pfizer
stem cells
Flag link:
Athersys Should Gain At Least 50%
Athersys Should Gain At Least 50%
Seeking Alpha
Athersys
stem cells
MultiStem
Flag link:
Athersys receives orphan drug designation for MultiStem
Athersys receives orphan drug designation for MultiStem
The Fly on the Wall
orphan drugs
MultiStem
Athersys
Flag link:
Athersys Releases Encouraging Results for Single Dose Arm of MultiStem
Athersys Releases Encouraging Results for Single Dose Arm of MultiStem
Seeking Alpha
Athersys
MultiStem
graft vs host disease
Flag link:
Athersys stem cell therapy wins scientists' plaudits
Athersys stem cell therapy wins scientists' plaudits
Mass Device
stem cells
Arthersys
MultiStem
Flag link:
Athersys Presents New Data and Advancements in Stem Cell and Drug Development Programs at Annual R&D Day
Athersys Presents New Data and Advancements in Stem Cell and Drug Development Programs at Annual R&D Day
Yahoo/Globe NewsWire
Athersys
MultiStem
stem cells
Flag link:
Pfizer Acquires a Stem-Cell Therapy
Pfizer Acquires a Stem-Cell Therapy
NY Times, NY
Pfizer
stem cells
MultiStem
M&A
Flag link: